Locoregional melanoma metastases resistant to PD-1 inhibitor therapy treated with intralesional talimogene laherparepvec.
JAAD Case Rep
; 43: 12-14, 2024 Jan.
Article
in En
| MEDLINE
| ID: mdl-38144943